Trials

Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial.

Ehinger E, Darabi A, Visse E, ..., Bengzon J, Siesjö P

Trials 26 (1) 86 [2025-03-13; online 2025-03-13]

COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial.

Welén K, Överby AK, Ahlm C, ..., Gisslén M, Josefsson A

Trials 22 (1) 209 [2021-03-16; online 2021-03-16]